November 2013 Life Science Industry Research Reports

Ophthalmology Therapeutics in Major Developed Markets to 2019 – New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies

Published in Nov 2013 ; US $ 3500 Onwards; Publisher: GBI Research

GBI Research has released its pharma research, “”Ophthalmology Therapeutics in Major Developed Markets to 2019 New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies””, which provides insights into two therapeutic indications in ophthalmology in […]

Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 – Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat

Published in Nov 2013 ; US $ 3500 Onwards; Publisher: GBI Research

GBI Research has released its pharmaceutical research, “”Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat””, which provides insights into three cardiovascular therapeutic indications in the top eight markets of […]

Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 – Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

Published in Nov 2013 ; US $ 3500 Onwards; Publisher: GBI Research

GBI Research has released its pharmaceutical research, “”Cardiovascular Diseases Therapeutics Market in Asia Pacific to 2019 Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use””, which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific […]